To include your compound in the COVID-19 Resource Center, submit it here.

Aradigm's Linhaliq gets PDUFA date

Aradigm Corp. (NASDAQ:ARDM) gained $0.83 (33%) to $3.36 on Monday after FDA

Read the full 126 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE